echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > "Chinese Expert Recommendations for the Diagnosis and Treatment of Acute Cerebral Infarction under DRG/DIP Payment Method" released, deepening medical reform and benefiting the people!

    "Chinese Expert Recommendations for the Diagnosis and Treatment of Acute Cerebral Infarction under DRG/DIP Payment Method" released, deepening medical reform and benefiting the people!

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The reform of medical insurance payment method is an important measure to deepen the reform of the medical system and medical security system, standardize the diagnosis and treatment behavior, reduce the burden of the people and ensure the smooth operation of the medical insurance fund, and the implementation of diagnosis-related group (DRG) and diagnosis-treatment package (DIP) payment is an important part of the implementation of
    medical insurance payment reform.
    The new situation of medical reform has brought new challenges to the sustainable development of hospitals, and also put forward new requirements
    for the standardized diagnosis and treatment and management of medical staff.
    As acute cerebral infarction is the most important disease causing death and disability in adults in China, there is still a lack of consensus on diagnosis and treatment under the background of the new medical reform in China, so it is imperative to formulate guidance and treatment recommendations for acute cerebral infarction under the DRG/DIP payment method
    .


    Implementing medical insurance reform and formulating consensus on diagnosis and treatment under new payment methods are important measures

      



    On December 29~31, 2022, the "Chinese Stroke Conference and the 12th National Cardiovascular and Cerebrovascular Disease Forum" jointly organized by the National Center for Neurological Diseases, the Chinese Preventive Medicine Association and the Chinese Geriatric Health Care Medical Research Association was grandly held
    online.
    On the 30th, at the "Thematic Forum on the Prevention and Treatment of Cerebrovascular Disease", the "Chinese Expert Recommendations for the Diagnosis and Treatment of Acute Cerebral Infarction under the Diagnosis-Related Groups or Diagnosis-Treatment Package Payment Method" (hereinafter referred to as the "Recommendations") formulated by the Physician Branch of the Chinese Medical Doctor Association organized by the domestic cerebrovascular disease related experts to establish an expert recommendation writing group was officially released
    .

    Professor Zeng Jinsheng said that the Recommendations are of great significance to how to standardize the prevention and treatment of cerebrovascular diseases in the new environment

    Professor Zeng Jinsheng, corresponding author of the Recommendation, Vice President of the First Affiliated Hospital of Sun Yat-sen University and leader of the Department of Neuroscience, introduced the entire background and writing process
    of the Recommendations on behalf of the Cerebrovascular Disease Expert Group of the Neurologists Branch of the Chinese Medical Doctor Association.
    Professor Zeng Jinsheng said that stroke is the most important cause of disability and death in China's population, especially acute cerebral infarction, which accounts for more than 80% of inpatients in neurology, but how to standardize the diagnosis and treatment of acute cerebral infarction under the DRG/DIP payment method, there is no relevant consensus and guidelines
    .

    Ischemic cerebrovascular disease has only "cerebral infarction" and related diagnostic entries in ICD-10 (International Classification of Diseases, 10th edition), and the background of the formulation of this Recommendation is not only related to the classification of cases, but also to
    national policies.
    Professor Zeng Jinsheng said that as early as 2017, China issued the "Opinions on Deepening the Reform of the Medical Security System", which specifically mentioned the diversified and composite medical insurance payment methods based on payment according to the type of disease, of which the most important is the DGR/DIP payment method
    .
    Therefore, under the leadership of President Yu Shengyuan, President Xie Peng and President Chen Xiaochun of the Physician Branch of the Chinese Medical Doctor Association, the expert group formulated this Recommendation for the first time
    .
    Its purpose and significance is to strictly diagnose and treat acute cerebral infarction, standardize the filling in of the first page of medical records and medical insurance settlement lists, and cooperate with the medical insurance department to promote medical insurance reform
    .

    Strengthen the awareness of DRG/DIP payment and change the concept of disease diagnosis and treatment

      


    Professor Ma Luning of the First Affiliated Hospital of Sun Yat-sen University analyzed the overview of DRG/DIP payment methods from the perspective of medical insurance administrators

    The Recommendations point out that DRG is divided into several diagnostic groups
    based on factors such as age, disease diagnosis, and comorbidities.
    The DRG payment method means that on the basis of DRG, the medical insurance management department no longer pays the medical institution according to the actual cost of the patient in the hospital, but pays according to the payment standard of the diagnosis-related group that the case enters
    .
    DIP is a disease-based payment
    under the total budget.
    The DIP payment method means that the medical insurance management department forms a payment standard based on the score of the disease and the value of the point value, and realizes standardized payment for each case of the medical institution, and no longer pays
    the cost of medical service items.
    DRG/DIP is a payment method
    based on the type of disease, based on the medical insurance settlement list, and based on the total medical cost as the control goal.
    At the same time, the implementation of DRG/DIP payment also needs to adhere to the integration of payment and supervision, and severely crack down on fraud and insurance fraud
    such as high arbitrage value.

    Expert advice



    • During the diagnosis and treatment of cerebral infarction, you should be familiar with the basic concepts and key points of DRG/DIP payment methods


    • Clinicians should pay attention to establishing cost awareness, and on the premise of ensuring medical quality and safety, reasonable diagnosis and treatment, and eliminate violations



    Following clinical guidelines and treatment paths is an important means to balance quality control costs

      


    Professor Yang Shanshan of the First Affiliated Hospital of Harbin Medical University interpreted the diagnostic process and principles of acute cerebral infarction under DGR/DIP mode

    Diagnostic recommendations

    Under the DRG/DIP payment method, in order to better fit the differentiated payment of the medical insurance system, the main diagnosis of acute cerebral infarction and the diagnosis format of complications or comorbidities should be strictly standardized, so it is necessary to clarify the relevant concepts and principles
    of diagnosis.


    The primary diagnosis refers to the disease identified by the medical institution as the main cause of the patient's hospitalization, and the other diagnosis refers to the disease during the patient's hospitalization that affects the treatment received and/or the length of the hospitalization.

    The main diagnosis should follow the principle of sequencing and classification, and avoid "high compilation and high dependence", that is, ordinary cerebral infarction diagnosis cannot be classified as severe cerebral infarction or hypochondriac comorbidities
    /complications
    .
    Complications refer to diseases that are directly caused by the primary diagnosis and have a causal relationship
    with the primary diagnosis.
    Comorbidities refer to diseases that are not directly related to the main diagnosis and complications, but have a certain impact on the course of this medical treatment, excluding previous diseases
    that do not affect this hospitalization.


    Expert advice



    • The main diagnosis of acute cerebral infarction directly determines the relevant grouping of patients for the diagnosis of core diseases, and should be as accurate and detailed as possible


    • The complications or comorbidities of acute cerebral infarction should be filled in in order according to the principle of severity from severe to mild and consumption of medical resources from more to less


    • Clinicians should communicate closely with the case coding department to ensure the accuracy of the main diagnosis and complications or comorbidities of acute cerebral infarction


    • Although the DGR/DIP payment method has not yet been implemented in emergency and outpatient clinics, it is still recommended to fill in the diagnosis and related operations of acute cerebral infarction in the emergency green channel, which is conducive to the improvement of payment management in the future



    Professor Dang Chao of the First Affiliated Hospital of Sun Yat-sen University interpreted the green channel diagnosis and treatment and hospitalization recommendations for patients with acute cerebral infarction

    Treatment recommendations

    DRG/DIP payment advocates the rational use of medical resources and limits excessive diagnosis and treatment
    .
    Therefore, the primary problem facing the diagnosis and treatment of acute cerebral infarction is how to balance the contradiction
    between improving the quality of diagnosis and treatment while reasonably controlling medical costs.
    At present, strict adherence to clinical guidelines and implementation of clinical pathways are considered to be an important means
    to balance this contradiction.
    The inpatient treatment process of acute cerebral infarction mainly includes general management and specific treatment
    .
    Specific management requires selection of therapies such as intravenous thrombolysis, bridging or direct endovascular intervention, antiplatelet therapy, anticoagulation, and fibrillation and volume expansion to restore blood perfusion or prevent recurrence
    , depending on the patient.
    In addition, China's guidelines also recommend the use of drugs
    including human urinary kinikrein to improve the collateral circulation of cerebral blood flow.

    Human urinary kininase is a class I chemical new drug
    developed in China to improve cerebral blood circulation.
    The "Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China 2018" formulated and released by the Neurology Branch of the Chinese Medical Association and its cerebrovascular disease group pointed out that in addition to restoring macrovascular recanalization, the degree of compensation of cerebral collateral circulation is closely related to the prognosis of acute cerebral infarction, and it is recommended to carry out further clinical research to find drugs or methods
    that are conducive to improving cerebral collateral circulation.

    Expert advice



    • The inpatient management of acute cerebral infarction should follow national guidelines, implement clinical pathways, standardize medications, and strictly grasp the indications and discharge criteria for withdrawal from clinical pathways



    Cooperate to accurately and standardize the filling in of the home page of the medical record

      


    Professor Song Haiqing of Xuanwu Hospital of Capital Medical University explained how to standardize the problem of filling in the first page of acute cerebral infarction cases, and the disease diagnosis and operation codes in the medical insurance settlement list are the main basis
    for DRG/DIP grouping 。 The code in the medical insurance settlement list comes from the home page of the medical record, and clinicians should fully understand the necessity of filling in the first page of the case in a standardized manner, write the relevant clinical diagnosis, surgery and operation information of acute cerebral infarction in a complete and standardized manner according to the order of lesion location, responsible blood vessel and etiology, and combine the disease classification rules and clinical knowledge to complete the accurate filling
    of the first page of the case with the case coder.

    Expert advice



    • Clinicians and case coders should be familiar with the ICD-10 diagnostic code for acute cerebral infarction, and the completion and coding of the first page of the case should be completed by the clinician and the coder
    • The diagnosis on the front page of the case should be preferentially based on the analysis of responsible vessels and etiology
      .
      Cerebral infarction in which the responsible blood vessels and etiology cannot be clarified, diagnosis can be given according to the location of cerebral infarction foci, or a special type of cerebral infarction can be used as the main diagnosis

    • Special treatments, procedures and surgeries should be completed on the first page of the medical record



    Rational use of medical insurance funds and standardization of outpatient secondary prevention diagnosis and treatment and follow-up still need attention

      


    Professor Cao Yongjun of the Second Affiliated Hospital of Soochow University interpreted the new version of the guidelines for the secondary prevention of cerebral infarction


    Professor Chen Huisheng of the Northern Theater General Hospital interpreted the etiology/risk factors and secondary prevention of cerebral infarction in young people


    At present, long-term effective secondary prevention in outpatient settings after discharge of patients with acute cerebral infarction is an important means to
    reduce recurrence and death.
    Although DRG/DIP codes have not yet been established for outpatient secondary prevention, the rational use of medical insurance costs should also be paid great attention to
    .

    Expert advice



    • Under the DRG/DIP payment method, the diagnosis of cerebral infarction in the secondary prevention of mid-stage in the outpatient clinic should be standardized according to the discharge summary and the home page of the case
    • Outpatient and secondary prevention drug use and imaging evaluation and follow-up should be standardized in combination with national guidelines and the patient's condition, and drugs and evaluation without evidence-based medical evidence should not be recommended



    Health economics tools can effectively solve the new problem of DRG/DIP payments

      


    In addition to inhibiting the application of innovative technologies and reducing patients' subjective feelings, the prepaid method of DRG/DIP may also cause problems such as the shift of the center of gravity of disease outcomes that are more closely related to clinical practice
    .
    This shift refers to the fact that under the DRG/DIP payment system per hospitalization, medical institutions tend to focus on short-term treatment outcomes and ignore long-term outcomes, which contradicts
    the goal of safeguarding the long-term health of patients.
    In this regard, through the two major tools in health economics, "cost-effect analysis" and "budget impact analysis", the problems
    that occur under the current DRG/DIP prepayment method can be effectively solved.

    Professor Wu Bo of West China Hospital of Sichuan University mentioned in introducing the correlation between kallikrein-kinin system (KKS) and the treatment of acute cerebral infarction that high levels of tissue kallikrein (TK) can help improve functional outcomes and reduce death in patients with acute cerebral infarction


    Taking drugs to improve cerebral collateral circulation as an example, a domestic economic evaluation and budget impact analysis study report on TK complementary therapy (Eureclin) showed that Eurecline can achieve a longer life cycle and a higher quality of life for patients with acute cerebral infarction, both from the perspective of cost and effect and from the perspective of budget impact, the study shows that Eurecline has better pharmacoeconomic advantages
    .


    Through pharmacoeconomics, assessing differences in economic efficiency between different interventions and the affordability of health insurance for new interventions, it is possible to fully discuss the impact of whether a healthcare facility procures, or applies a drug in the clinical pathway, on the overall cost and revenue of the healthcare organization, thereby estimating the impact
    on the overall financial situation.

    Expert advice



    • Correctly treat the new problems faced by DRG/DIP payment methods, and promote the refined management of hospital internal operations
    • Health economics tools are applied to monitor and analyze hospital data quality and medical behavior, and timely solve the problems of inhibition of clinical application of innovative technologies, shift in the center of gravity of disease outcomes, and reduced medical quality of patients' subjective perception under DRG/DIP payment methods

    summary

      


    DGR/DIP is an inevitable reform and has gradually become an important factor affecting clinical diagnosis and treatment, and the standardized management of acute cerebral infarction under the DGR/DIP mode is worth learning from clinicians
    .
    The Chinese Expert Recommendations for the Diagnosis and Treatment of Acute Cerebral Infarction under DRG or DIP Payment provides a reference
    for clinicians, medical insurance administrators and pharmacoeconomics experts in the critical period of medical insurance policy reform in the clinical diagnosis and treatment of acute cerebral infarction, medical insurance settlement and promotion of medical insurance payment reform.
    At present, clinical work under DRG/DIP payment methods faces many problems, such as clinicians' lack of understanding of DRG/DIP payment methods; The payment of medical expenses for diseases of the same group varies greatly in different regions, and all need to be further improved
    .
    It is hoped that this new model can continue to promote the further deepening of medical reform and form a more scientific, systematic and long-term medical insurance payment system to benefit the majority of patients
    .


    References:
    1.
    Cerebrovascular Disease Expert Group, Neurologist Branch of Chinese Medical Doctor Association.
    Chinese expert recommendations for the diagnosis and treatment of acute cerebral infarction under diagnosis-treatment package payment method[R].
    Chinese Stroke Conference.
    2022.
    2.
    Neurology Branch of Chinese Medical Association, Cerebrovascular Disease Group of Neurology Branch of Chinese Medical Association.
    Chinese guidelines for the diagnosis and treatment of acute ischemic stroke 2018[J].
    Chinese Journal of Neurology.
    2018,51(9):666-682
    3.
    Beijing Medical and Health Economics Research Association.
    Research report on pharmacoeconomic evaluation and budget impact analysis of Eureclin injection[R].
    Beijing:Beijing Medical and Health Economics Research Association.
    2021.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.